INTRODUCTORY REMARKS (<Session 6B>Safety assessment of biotechnology-derived pharmaceutical product.)
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 1996-12-20
著者
-
Inoue Tohru
Biological Safety Research Center, National Institute of Health Sciences
-
Maki Eiji
Preclinical Development Dept. Janssen-kyowa Co. Ltd.
-
Maki Eiji
Precli. Develop. Dept. Res. & Develop. Divi. Janssen-kyowa Co. Ltd.:japan Pharmaceutical Manufac
-
Inoue Tohru
Biological Safety Res. Center National Inst. Of Health Sciences
-
Inoue Tohru
Biological Safety Research Center National Institute Of Health Sciences
関連論文
- Aryl hydrocarbon receptor (AhR) mediated hematotoxicity induced by benzene.(GENERAL SESSION BY ORAL PRESENTATION)(BLOOD SYSTEM & HEMATOLOGY)
- Safety assessment of biopharmaceuticals : Japanese perspective on ICH S6 guideline maintenance
- Points to consider on the non-clinical safety evaluation of anticancer drugs
- "POINTS TO CONSIDER" REGARDING SAFETY ASSESSMENT OF BIOTECHNOLOGY-DERIVED PHARMACEUTICALS IN NON-CLINICAL STUDIES (ENGLISH TRANSLATION)
- Toxicity study of Garcinia cambogia extract II : A28-day dietary exposure of hydroxycitric acid, a principal ingredient of Garcinia cambogia extract, on testicular toxicity in rats. (GENERAL TOXICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings
- Toxicity study of Garcinia canbogia extract I : A 52-week-toxicity study of Garcinia cambogia extract in rats (GENERAL TOXICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Cellular-Evenrs during Radiation-Induced Thymic Lymphomagenesis in p53 Heterozygous(+/-)Mice
- The Dose-response Relationships for Undifferentiated Leukemia in p53-deficient C3H/He mice
- "P-27 Local irritation effects in the nasal cavity and the nasopharyngeal epithelia of the rat treated per os for 10 days with repeated doses of N-(fluorodichloromethylthio) phthalimide ("fluor-folpet").
- 21B-10-4 Benzene hemopoietic toxicity revisited- a new concept.
- 3A-09 Hemopoietic Stem-Cell Kinetics Evaluated by Bromodeoxyuridine Incorporation Followed by Near-UV Exposure to Kill Cycling Stem Cells (BUUV). 2) Bone Marrow Cells from Mice Carrying Human c-myc Proto-Oncogene with Promoters Combined with Immunoglobuli
- WI-01 The Present Status of ICH Guideline for Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
- S1-7 Tolerance inductions of mice carrying TRX/ADF over-expression for environmental stress
- Report 1 : GENERAL PRINCIPLES AND THE RELEVANT CASES (Safety assessment of biotechnology-derived pharmaceutical product.)
- INTRODUCTORY REMARKS (Safety assessment of biotechnology-derived pharmaceutical product.)